These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 10354780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 3. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission].
    Suzuki R, Iida H, Taji H, Murata M, Sugihara T, Minami S, Kodera Y.
    Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123
    [Abstract] [Full Text] [Related]

  • 4. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K.
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
    [Abstract] [Full Text] [Related]

  • 5. [Access to bone marrow transplantation in acute myeloblastic leukemia. Study of 52 patients treated in a single center].
    Tomás JF, Calvo JM, Gómez-García de Soria V, Pinilla I, Figuera A, Fernández-Rañada JM.
    Med Clin (Barc); 1997 May 31; 109(1):12-5. PubMed ID: 9303971
    [Abstract] [Full Text] [Related]

  • 6. Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.
    Brandwein JM, Gupta V, Schuh AC, Schimmer AD, Yee K, Xu W, Messner HA, Lipton JH, Minden MD.
    Am J Hematol; 2008 Jan 31; 83(1):54-8. PubMed ID: 17696207
    [Abstract] [Full Text] [Related]

  • 7. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.
    Dufoir T, Saux MC, Terraza B, Marit G, Guessard S, Foulon G, Reiffers J.
    Bone Marrow Transplant; 1992 Oct 31; 10(4):323-9. PubMed ID: 1422487
    [Abstract] [Full Text] [Related]

  • 8. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V.
    J Med Assoc Thai; 2009 Sep 31; 92(9):1143-9. PubMed ID: 19772172
    [Abstract] [Full Text] [Related]

  • 9. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.
    Blaise D, Attal M, Reiffers J, Michallet M, Bellanger C, Pico JL, Stoppa AM, Payen C, Marit G, Bouabdallah R, Sotto JJ, Rossi JF, Brandely M, Hercend T, Maraninchi D.
    Eur Cytokine Netw; 2000 Mar 31; 11(1):91-8. PubMed ID: 10705305
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia.
    Lashkari A, Lowe T, Collisson E, Paquette R, Emmanouilides C, Territo M, Schiller G.
    Biol Blood Marrow Transplant; 2006 Apr 31; 12(4):466-71. PubMed ID: 16545730
    [Abstract] [Full Text] [Related]

  • 11. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C, Lacerda JF, Lourenço F, Carmo JA, Lacerda JM.
    Acta Med Port; 2005 Apr 31; 18(5):329-37. PubMed ID: 16611537
    [Abstract] [Full Text] [Related]

  • 12. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D, Chelghoum Y, Le QH, Elhamri M, Michallet M, Thomas X.
    Ann Hematol; 2003 Nov 31; 82(11):684-90. PubMed ID: 12928754
    [Abstract] [Full Text] [Related]

  • 13. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2008 Jun 31; 93(6):834-41. PubMed ID: 18469352
    [Abstract] [Full Text] [Related]

  • 14. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
    Ayash LJ, Ratanatharathorn V, Braun T, Silver SM, Reynolds CM, Uberti JP.
    Am J Hematol; 2007 Jan 31; 82(1):6-14. PubMed ID: 16986128
    [Abstract] [Full Text] [Related]

  • 15. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
    Alymara V, Tzouvara E, Vartholomatos G, Chaidos A, Tsiara S, Bourantas KL.
    J Exp Clin Cancer Res; 2004 Sep 31; 23(3):447-54. PubMed ID: 15595635
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D.
    Biol Blood Marrow Transplant; 2004 May 31; 10(5):310-9. PubMed ID: 15111930
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH, Feng SZ, Wang M, Wei JL, Jiang EL, Zhang L, Huang Y, Zhou SY, Liu QG, Qiu LG, Han MZ, Yan WW.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul 31; 25(7):389-92. PubMed ID: 15355688
    [Abstract] [Full Text] [Related]

  • 18. Outcome of patients with acute myelogenous leukemia after second salvage therapy.
    Giles F, O'Brien S, Cortes J, Verstovsek S, Bueso-Ramos C, Shan J, Pierce S, Garcia-Manero G, Keating M, Kantarjian H.
    Cancer; 2005 Aug 01; 104(3):547-54. PubMed ID: 15973664
    [Abstract] [Full Text] [Related]

  • 19. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
    Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Bénard A, Bordigoni P, Gandemer V, Thuret I, Dalle JH, Piguet C, Pautard B, Baruchel A, Leverger G, French Society of Pediatric Hematology and Immunology.
    J Clin Oncol; 2003 Dec 01; 21(23):4377-85. PubMed ID: 14645428
    [Abstract] [Full Text] [Related]

  • 20. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T, Ueda T.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25(3):295-302. PubMed ID: 9492819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.